24 January 2018

A Midland hospital has been praised for the quality of its care for patients with myeloma.

Myeloma UK has named the Royal Stoke University Hospital, of University Hospitals of North Midlands NHS Trust as recipient of its 'Clinical Service Excellence Programme Award.’

The charity says the award recognises the hospital's outstanding quality of care provided to myeloma patients.

Suzanne Renwick of Myeloma UK said: "Being presented with the Myeloma UK Clinical Service Excellence Programme Award is a considerable achievement and shows that University Hospitals of North Midlands is dedicated to providing excellent treatment and care.

"The Myeloma UK CSEP award demonstrates the gold standard of myeloma care."

Consultant Haematologist at the Trust, Dr Kamaraj Karunanithi, said: "Every day 15 people are diagnosed with myeloma in the UK. Myeloma is often difficult to diagnose, as symptoms may be non-specific.

“In the last ten years, with improvements in treatment and care, survival rates are increasing faster than most other cancers. Despite this, the diagnosis is often delayed, and most patients ultimately die from their myeloma.

"The work we are doing here at University Hospitals of North Midlands ensures local myeloma patients can access top-quality care and ground-breaking research. I am delighted we have been given this award."

One patient treated at Royal Stoke University Hospital, Malcolm Scovell, commented: "The haematology team really understand and deliver first rate clinical and client service. As a myeloma patient under their care for the last three years I have experienced and benefitted from most of the services that are offered.

"This cohesive unit from reception, consultation, both planned and unplanned treatment as an inpatient and ongoing outpatient care and not forgetting the help from the trials team and the dedicated patient liaison nurse, all play their part. They have gained my trust and I would recommend the entire team to anyone."


Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in Haematology. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.

News service provided by Englemed News http://www.englemed.co.uk/